The Gut Microbiome and Autoimmune Hepatitis: Implications for Early Diagnostic Biomarkers and Novel Therapies
Molecular Nutrition & Food Research · 2023
DOI: 10.1002/mnfr.202300043 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Nutrition & Food Research, 2023. Verfasst von Liping Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, 030001, China. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Gastrointestinal Microbiome, Liver Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Shanxi Province Natural, Science Foundation, Science Research Start-up Fund for Doctor of Shanxi Medical University.
Abstract (Originalsprache)
Autoimmune hepatitis (AIH) is a serious chronic liver disease that may last for decades and eventually develop into cirrhosis and liver failure. In recent years, people have paid more attention to the microbiome‐gut‐liver axis, which provides guidance for all to explore the role of microbiome in the occurrence and development of liver diseases. In this review, the possible mechanism of intestinal microbes promoting the occurrence of AIH, mainly expounding the key ways such as bacterial ecological imbalance, intestinal leakage, and molecular simulation between microbes and autoantigens is summarized. In addition, this paper also discusses that intestinal microbiome has great potential as a biomarker for early diagnosis of AIH, and intestinal microbiome is also a candidate target for prevention and treatment of AIH. Finally, the study summarizes and prospects the targeted therapy of intestinal microorganisms to prevent the occurrence and development of AIH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
ORCID-Profile: Yongbo Kang
Förderung
- Shanxi Province Natural
- Science Foundation
- Science Research Start-up Fund for Doctor of Shanxi Medical University
- Science Research Start-up Fund for Doctor of Shanxi Province
- Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi
- Shanxi Province Science Foundation for Youths
Zitieren
APA
Li, L., & Kang, Y. (2023). The Gut Microbiome and Autoimmune Hepatitis: Implications for Early Diagnostic Biomarkers and Novel Therapies. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300043
Vancouver
Li L, Kang Y. The Gut Microbiome and Autoimmune Hepatitis: Implications for Early Diagnostic Biomarkers and Novel Therapies. Molecular Nutrition & Food Research. 2023. doi:10.1002/mnfr.202300043
BibTeX
@article{Li2023,
author = {Li, Liping and Kang, Yongbo},
title = {The Gut Microbiome and Autoimmune Hepatitis: Implications for Early Diagnostic Biomarkers and Novel Therapies},
journal = {Molecular Nutrition & Food Research},
year = {2023},
doi = {10.1002/mnfr.202300043}
}
EUVIMED